We are live on ! Find out more
EMFAT

Emerald Mutual Fund Advisers Trust Portfolio holdings

AUM $2.06B
1-Year Est. Return 106.87%
This Fund
S&P 500
This Quarter Est. Return
+5.95%
1 Year Est. Return
+106.87%
3 Year Est. Return
+347.49%
5 Year Est. Return
+440.43%
10 Year Est. Return
+3,482.63%
AUM
$1.78B
AUM Growth
+$2.46M
Cap. Flow
-$31.4M
Cap. Flow %
-1.76%
Top 10 Hldgs %
16.9%
Holding
298
New
31
Increased
107
Reduced
62
Closed
31

Sector Composition

Rank Sector Weight
1 Financials 22.12%
2 Technology 16.97%
3 Consumer Discretionary 15.72%
4 Healthcare 11.15%
5 Industrials 10.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WFBI
126
DELISTED
WashingtonFirst Bankshares Inc
WFBI
$4.06M 0.23%
197,059
MLVF
127
DELISTED
Malvern Bancorp, Inc.
MLVF
$4.04M 0.23%
259,003
GWB
128
DELISTED
Great Western Bancorp, Inc.
GWB
$3.96M 0.22%
125,723
+659
+0.5% +$20.5K
OMCL icon
129
Omnicell
OMCL
$1.61B
$3.95M 0.22%
115,417
+76,074
+193% +$2.37M
TLYS icon
130
Tilly's
TLYS
$116M
$3.92M 0.22%
676,900
BNCN
131
DELISTED
BNC Bancorp
BNCN
$3.9M 0.22%
171,605
MBUU icon
132
Malibu Boats
MBUU
$541M
$3.88M 0.22%
321,408
-51,910
-14% -$758K
XRN
133
Chiron Real Estate Inc
XRN
$514M
$3.87M 0.22%
+76,622
New +$3.85M
SMCI icon
134
Super Micro Computer
SMCI
$18.4B
$3.82M 0.21%
1,536,610
-3,414,910
-69% -$9.37M
IPHI
135
DELISTED
INPHI CORPORATION
IPHI
$3.81M 0.21%
119,058
-119,280
-50% -$3.74M
EVDY
136
DELISTED
Everyday Health, Inc.
EVDY
$3.63M 0.2%
460,661
RETA
137
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$3.6M 0.2%
+182,390
New +$3.55M
AIMT
138
DELISTED
Aimmune Therapeutics
AIMT
$3.6M 0.2%
332,625
+3,970
+1% +$53.9K
WAL icon
139
Western Alliance Bancorporation
WAL
$8.79B
$3.55M 0.2%
108,804
-91,340
-46% -$3.21M
NEO icon
140
NeoGenomics
NEO
$1.96B
$3.42M 0.19%
+425,820
New +$3.41M
HBMD
141
DELISTED
Howard Bancorp, Inc. Common Stock
HBMD
$3.41M 0.19%
262,499
OCFC icon
142
OceanFirst Financial
OCFC
$1.68B
$3.32M 0.19%
182,919
SIGM
143
DELISTED
Sigma Designs Inc
SIGM
$3.31M 0.19%
514,084
-262,388
-34% -$1.74M
TCRT icon
144
Alaunos Therapeutics
TCRT
$4.59M
$3.28M 0.18%
3,978
+120
+3% +$131K
SRCE icon
145
1st Source
SRCE
$2.16B
$3.24M 0.18%
100,000
CSFL
146
DELISTED
CenterState Bank Corporation Common Stock
CSFL
$3.2M 0.18%
203,323
SFNC icon
147
Simmons First National
SFNC
$3.41B
$3.06M 0.17%
132,472
FFWM
148
DELISTED
First Foundation Inc
FFWM
$3.05M 0.17%
284,074
-136,798
-33% -$1.51M
CNOB icon
149
Center Bancorp
CNOB
$1.66B
$2.99M 0.17%
190,470
-442,307
-70% -$7.14M
NH
150
DELISTED
NantHealth, Inc
NH
$2.9M 0.16%
+15,471
New +$3.37M

Similar funds

Emerald Mutual Fund Advisers Trust's Q2 2016 Portfolio in Review

As of Q2 2016, Emerald Mutual Fund Advisers Trust held 298 positions worth $1.78B, up 0.14% from $1.78B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Emerald Mutual Fund Advisers Trust's Q2 2016 filing shows 31 new, 107 increased, 62 reduced and 31 closed positions. Its largest new stake was Dycom Industries: 176,927 shares worth $15.9M. The largest sale was PrivateBancorp Inc, an estimated $21.7M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Emerald Mutual Fund Advisers Trust's largest Q2 2016 buy was Dycom Industries: 176,927 shares worth $15.9M.
  • Emerald Mutual Fund Advisers Trust added most to CyrusOne Inc Common Stock in Q2 2016, an estimated $17.4M increase.
  • Emerald Mutual Fund Advisers Trust's biggest Q2 2016 reduction was PrivateBancorp Inc, cutting an estimated $21.7M.
  • Emerald Mutual Fund Advisers Trust fully exited Virgin America Inc. in Q2 2016, selling an estimated $11.7M.
  • Emerald Mutual Fund Advisers Trust's ten largest holdings make up 17% of its $1.78B portfolio in Q2 2016.
  • Emerald Mutual Fund Advisers Trust opened 31 new positions and closed 31 in Q2 2016.
  • Emerald Mutual Fund Advisers Trust's portfolio value rose 0.14% quarter-over-quarter to $1.78B.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q2 2016, filed 28 Jul 2016.